A Form 4 filed with the SEC on August 7, 2026 disclosed that D. Anthony Peay, a director of C & F Financial Corp (NASDAQ: CFFI), sold 425 shares of common stock on August 5, 2026.
A Form 4 filed on August 7, 2026 discloses that Maggie Yuen, a director of AtriCure, Inc. (NASDAQ: ATRC), sold 3,500 shares of common stock on August 5, 2026 at a weighted average price of $38.42 per share.
A Form 4 filed with the SEC on August 7, 2026, discloses that Karen Prange, a director of AtriCure, Inc. (NASDAQ: ATRC), sold 3,564 shares of common stock on August 5, 2026.
A Form 4 filed on August 7, 2026, with the U.S. Securities and Exchange Commission reports that Robin Peppe Sterneck, a director of EPR Properties (EPR), sold 3,403 common shares of beneficial interest on August 6, 2026, through a revocable trust.
Judy Anderson, Vice President and CFO of Weyco Group Inc, filed a Form 4 on August 7, 2026, disclosing the sale of 2,602 shares of common stock on that same date.
Allison Woss, Vice President of Supply Chain at Weyco Group Inc, filed a Form 4 on August 7, 2026, disclosing the sale of 2,511 shares of common stock on that same date.
Director Leonard R. Goldberg filed a Form 4 with the SEC on August 7, 2026, reporting the acquisition of restricted ordinary shares in Greenlight Capital Re, Ltd. (NASDAQ: GLRE) at no cost under the company's 2023 Omnibus Incentive Plan.
David Bryant Mitchell, Chief Wholesale Banking Officer at FNB Corp/PA/, filed a Form 4 on August 7, 2026, disclosing a sale of common stock executed on August 6, 2026.
Nikolaos Reskos, Chief Operating Officer of Star Bulk Carriers Corp., filed a Form 4 on August 7, 2026, disclosing the sale of 5,000 common shares on August 6, 2026, pursuant to a Rule 10b5-1 trading plan.
Tango Therapeutics, Inc. filed a Form 8-K/A on August 7, 2026, amending its earlier current report to disclose the executed separation agreement with Barbara Weber, M.D., whose employment as Executive Chair ended effective August 3, 2026.